The Importance of a Timely Second Dose of the 2021 COVID-19 mRNA Vaccine Depends on the Protection Afforded by a First Dose and Subsequent Risk of Anaphylaxis

Vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) represents our greatest hope to combat the devastating coronavirus disease 2019 (COVID-19) pandemic. Amid ongoing global vaccination efforts, rare cases of severe allergic reactions to COVID-19 mRNA vaccines have receiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Shaker, Marcus, Phillips, Elizabeth, Blumenthal, Kimberly G., Abrams, Elissa M., Banerji, Aleena, Oppenheimer, John, Vander Leek, Timothy K., Mack, Douglas P., Wickner, Paige G., Singer, Alexander G., Khan, David A., Greenhawt, Matthew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Academy of Allergy, Asthma & Immunology 2021
Materias:
Review and Feature Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8056986/
https://www.ncbi.nlm.nih.gov/pubmed/33892171
http://dx.doi.org/10.1016/j.jaip.2021.04.015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8056986/
https://www.ncbi.nlm.nih.gov/pubmed/33892171
http://dx.doi.org/10.1016/j.jaip.2021.04.015

Ejemplares similares